Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06NMZ
|
|||
Former ID |
DNC001052
|
|||
Drug Name |
NVP-ADW742
|
|||
Synonyms |
NVP-ADW742; 475488-23-4; ADW-742; 475489-15-7; UNII-MXS2N5862L; ADW742; MXS2N5862L; CHEMBL399021; 5-(3-(Benzyloxy)phenyl)-7-((1r,3r)-3-(pyrrolidin-1-ylmethyl)-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; 5-(3-(Benzyloxy)phenyl)-7-(cis-3-(pyrrolidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; C28H31N5O; 5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Investigative | [1] | |
Company |
Novartis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H31N5O
|
|||
Canonical SMILES |
C1CCN(C1)CC2CC(C2)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC=C5)OCC6=CC=CC=C6
|
|||
InChI |
1S/C28H31N5O/c29-27-26-25(22-9-6-10-24(15-22)34-18-20-7-2-1-3-8-20)17-33(28(26)31-19-30-27)23-13-21(14-23)16-32-11-4-5-12-32/h1-3,6-10,15,17,19,21,23H,4-5,11-14,16,18H2,(H2,29,30,31)
|
|||
InChIKey |
LSFLAQVDISHMNB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 475488-23-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
14784297, 15167856, 24127797, 44923287, 53837761, 74517124, 103550967, 103904996, 104092611, 117695996, 124756989, 125163794, 131480752, 134340305, 136367288, 137778791, 139380001, 140885742, 141546423, 144116293, 152258154, 160646991, 162011873, 162037425, 162202652, 163907941, 164339439, 174006571, 174529497, 180190868, 186014832, 202553532, 223397881, 226472395, 228142956, 228142958, 241377378, 242526284, 242800901, 245990226, 248492712, 251963182, 252110001, 252158717, 252215927, 252437621, 252823856
|
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging therapies for multiple myeloma. Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.